SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing heightened volatility and speculative activity driven by conflicting reports surrounding a potential U.S.-Iran peace deal and widespread anticipation ahead of the historic SpaceX IPO. Community discourse reflects a deeply polarized market, with retail participants debating whether the IPO and geopolitical news represent genuine market catalysts or calculated maneuvers for liquidity and market manipulation.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust (QQQ) is seeing significant volatility driven by market participants reacting to President Trump's statements regarding potential peace agreements with Iran, which triggered a sudden influx of buying. The community remains deeply polarized, with many traders debating whether this surge represents a legitimate geopolitical breakthrough or a tactical "pump" intended to provide liquidity for the high-profile SpaceX (SPCX) IPO.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing a volatile market reaction despite reporting record revenue and raised guidance, as investors weigh strong AI integration against concerns over leadership turnover following the CFO's resignation. The community is sharply divided, with many calling this a deep-value opportunity based on fundamental strength and aggressive buybacks, while skeptics view the stock as a long-term value trap facing obsolescence from AI competitors.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is capturing significant market attention following its formal inclusion in the Nasdaq-100 index, a milestone that community members view as a key catalyst for structural institutional demand and increased liquidity. While some participants are wary of historical insider selling and capital-intensive growth strategies, bullish investors remain focused on the companys massive revenue backlog and its critical role in expanding AI infrastructure capacity.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently seeing high volatility as institutional investors rotate capital out of semiconductor stocks to secure liquidity for the upcoming SpaceX IPO. The community is deeply divided between long-term investors holding for a fundamental AI-driven breakout and traders debating whether the stock is trapped in a bear market following recent macroeconomic headwinds.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative interest as retail participants debate the project's long-term utility against recent price consolidation. The community remains deeply polarized, with some investors accumulating tokens in anticipation of ecosystem expansion and Japanese regulatory shifts, while others express frustration over stagnant price action and comparisons to newer projects.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is trending as investors grapple with conflicting signals from geopolitical tensions in the Middle East and mixed economic data, while the community intensely debates whether the market is detached from reality due to ongoing volatility and aggressive central bank policies. Traders remain focused on potential liquidity rotations ahead of major upcoming IPOs and significant inflationary pressure, reflecting a broader sentiment of skepticism regarding the current market rally.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense selling pressure as investors rotate capital out of software heavyweights to fund positions in the highly anticipated SpaceX IPO. The community is sharply divided, with bearish voices highlighting a perceived lack of immediate AI monetization and institutional liquidation, while bullish traders view the recent dip as an undervalued buying opportunity for a foundational enterprise player.

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is experiencing a massive surge in volume and retail interest as investors capitalize on the "halo effect" surrounding the highly anticipated SpaceX IPO, with many treating the stock as a high-beta proxy for the broader space sector. The community is actively debating whether the rally is a speculative "meme" play fueled by ticker confusion or a fundamental turnaround, while traders closely watch high short interest and call option activity for potential short and gamma squeeze setups.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is currently trending as investors focus on positive Phase 1 clinical data for subcutaneous Briumvi in myasthenia gravis, which has fueled speculation regarding a potential buyout and expansion into new indications. Community sentiment remains heavily bullish, with shareholders actively debating the timing of a strategic acquisition and the long-term potential for the stock as it gains momentum among institutional investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

Here is how ALX Oncology Holdings Inc. (ALXO) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

ALX Oncology (ALXO) to Release Quarterly Earnings on Thursday

ALX Oncology (NASDAQ:ALXO) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-alx-oncology-holdings-inc-stock...

ALX Oncology (NASDAQ:ALXO) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded ALX Oncology from a "hold" rating to a "sell" rating in a research report on Saturday...

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

BIAF is sharpening its focus on CyPath Lung, streamlining unprofitable services and pushing validation studies as it expands its lung-disease pipeline.

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six research firms that are currently covering the company, MarketBeat...

ALX Oncology (NASDAQ:ALXO) CEO Sells $26,714.87 in Stock

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) CEO Jason Lettmann sold 12,311 shares of the company's stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $2.17, for a total value of $26,714.87. Following the transaction, the chief...

Insider Selling: ALX Oncology (NASDAQ:ALXO) CEO Sells 12,311 Shares of Stock

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) CEO Jason Lettmann sold 12,311 shares of the firm's stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an...

Wells Fargo & Company Begins Coverage on ALX Oncology (NASDAQ:ALXO)

Wells Fargo & Company initiated coverage on ALX Oncology in a research note on Thursday. They issued an "overweight" rating and a $5.00 target price for the company...

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

Aldeyra Therapeutics stock plunges 71% after the FDA issues a third CRL for the resubmitted reproxalap NDA for the treatment of dry eye disease.

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

ALXOAlx Oncology Holdings Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALXO News